AGT-110

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAGT-110
Drug Alias NameAGT-110
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseStroke +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseStroke +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A